Literature DB >> 30180998

Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review.

Neus Muñoz1, Jordi Sánchez-Delgado2, Mireia Baylina3, Sheila López-Góngora3, Xavier Calvet2.   

Abstract

There are no systematic data on the rates of antibiotic resistance after the failure of a first eradication treatment. The objective of this study was to determine the prevalence of secondary resistance to antibiotics by conducting a systematic review of studies evaluating the secondary resistance of Helicobacter pylori. We identified 31 studies (2,787 patients). Resistance was determined in 1,764 patients. A percentage of 99.1 of patients received clarithromycin as first-line treatment and 58.7% developed resistance. A percentage of 24.3 received metronidazole and 89.7% developed resistance. Secondary resistance to amoxicillin was extremely rare. Secondary resistance after first-line treatment was very common. These findings support the recommendation not to repeat clarithromycin or metronidazole after the failure of a first eradication treatment.
Copyright © 2018 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Helicobacter pylori; Resistances; Resistencias; Second-line; Segunda línea

Mesh:

Substances:

Year:  2018        PMID: 30180998     DOI: 10.1016/j.gastrohep.2018.06.014

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  1 in total

1.  Comparison of Vonoprazan and Amoxicillin Dual Therapy with Standard Triple Therapy with Proton Pump Inhibitor for Helicobacter Pylori eradication: A Randomized Control Trial.

Authors:  Bader Faiyaz Zuberi; Faiza Sadaqat Ali; Tazeen Rasheed; Nimrah Bader; Sana Muhammad Hussain; Anoshia Saleem
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.